{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:15:18Z","timestamp":1788261318702,"version":"build-2803163510"},"reference-count":104,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"crossref","award":["NRR26\/043\/7"],"award-info":[{"award-number":["NRR26\/043\/7"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/13543776.2026.2713553","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:07:18Z","timestamp":1785575238000},"page":"849-864","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["T-type calcium channel blockers: a review of recent advances (2018\u20132025)"],"prefix":"10.1080","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-0170","authenticated-orcid":false,"given":"Yasinalli","family":"Tamboli","sequence":"first","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGH)","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-7417","authenticated-orcid":false,"given":"Laurent","family":"Ferron","sequence":"additional","affiliation":[{"name":"University of Calgary","place":["Calgary, Canada"]},{"name":"University of Calgary","place":["Calgary, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-9066","authenticated-orcid":false,"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[{"name":"University of Calgary","place":["Calgary, Canada"]},{"name":"University of Calgary","place":["Calgary, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009654"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2002"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.12-10-03804.1992"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-2888-2_33"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.4161\/cib.19997"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.5"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00023.2013"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-012-1211-y"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.4161\/chan.4953"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-022-00923-w"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17337"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600515"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13906"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2021.01.002"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20241877"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.07.036"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.4c00316"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12080_2"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00663-9"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00762-1"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C400006200"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1817-06.2007"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00736-3"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00861-z"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/19336950.2016.1204497"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00577-6"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab101"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1011828"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101337"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy145"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00700-7"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106163"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1801-3"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-024-00959-8"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29728-0"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2011.536532"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2018.1541982"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114716"},{"key":"e_1_3_5_41_1","unstructured":"Kinki University National University Corporation University of Toyama Fuso Pharmaceutical Industries Ltd. T-type calcium channel blocker. US 2024\/0287019 A1 2024."},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-00742"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2680.1999.00135.x"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.02.059"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-10-77"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1086243"},{"key":"e_1_3_5_47_1","unstructured":"UTI Limited Partnership University of Montana. T-type calcium channel modulator and uses thereof. US 10227332. 2019 p. B2."},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16035"},{"key":"e_1_3_5_49_1","unstructured":"Praxis Precision Medicines Inc. Monash University. T-type calcium channel modulators and methods of use thereof. US 2021\/0128537 A1. 2021."},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00009.x"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.2165\/11204490-000000000-00000"},{"key":"e_1_3_5_52_1","unstructured":"AFASCI Inc. Methods of treating hypersensitive cough or itching using ion channel inhibitory compounds. US 11744825. 2023 p. B2."},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00256"},{"key":"e_1_3_5_54_1","unstructured":"Arizona Board of Regents on Behalf of the University of Arizona. Small molecule inhibitors of Cav3.2 activity and uses thereof. US 2023\/0192674 A1. 2023."},{"key":"e_1_3_5_55_1","unstructured":"Arizona Board of Regents on Behalf of the University of Arizona. Small molecule inhibitors of calcium channel activity and uses thereof. US 2023\/0365544 A1. 2023."},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2CS00478J"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00083"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-018-0405-4"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0011-8"},{"key":"e_1_3_5_60_1","unstructured":"Zymedyne Therapeutics Inc. T-type calcium channel modulators. WO 2024\/178505 A1. 2024."},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00765"},{"key":"e_1_3_5_62_1","unstructured":"The Board of Trustees of the Leland Stanford Junior University Acurex Therapeutics. Cav3.2 T-type calcium channel modulators and methods of use thereof. WO 2022\/216664 A2. 2022."},{"key":"e_1_3_5_63_1","unstructured":"Merck Sharp & Dohme Corp. Pyridyl amide T-type calcium channel antagonists. US 7875636 B2 2011."},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13195013"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.3109\/14756360903524304"},{"key":"e_1_3_5_66_1","unstructured":"Idorsia Pharmaceuticals Ltd. Triazole compounds as T-type calcium channel blockers. US 10246426B2. 2019."},{"key":"e_1_3_5_67_1","unstructured":"Nippon Chemiphar Co. Ltd. Kinki University. Voltage-dependent T-type calcium channel blocker. US 11420944. 2022 p. B2."},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000565"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.10.023"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1159\/000449449"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1212800"},{"key":"e_1_3_5_72_1","unstructured":"Nippon Chemiphar Co. Ltd. UTI Limited Partnership Kinki University. Use of T-type calcium channel blocker for treating pruritus. US 2022\/0226299 A1 2022."},{"key":"e_1_3_5_73_1","unstructured":"Nippon Chemiphar Co. Ltd. Kinki University. T-type calcium channel blocker. US 2022\/0363667 A1. 2022."},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116766"},{"key":"e_1_3_5_75_1","unstructured":"University of Maryland Eastern Shore. Calcium channel blockers and methods thereof. US 2024\/0382438 A1. 2024."},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.04.090"},{"key":"e_1_3_5_77_1","unstructured":"University-Industry Cooperation Group of Kyung Hee University. 3 4-dihydroquinazoline derivative and complex preparation containing same. WO 2015\/178608 A2. 2015."},{"key":"e_1_3_5_78_1","unstructured":"Boryung Pharmaceutical Co. Ltd. University-Industry Cooperation Group of Kyung Hee University. Novel compound method for preparing same and pharmaceutical composition comprising same. WO 2014\/021591 A2. 2014."},{"key":"e_1_3_5_79_1","unstructured":"OncoZen Co. Ltd. Pharmaceutical composition for treating and preventing triple-negative breast cancer. WO 2025\/143655 A1 2025."},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115491"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1177\/1744806916641678"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90130-9"},{"key":"e_1_3_5_84_1","unstructured":"University of Virginia Patent Foundation. T type calcium channel inhibitors. US 10369120. 2019 p. B2."},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78800-0"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050673"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.01.029"},{"key":"e_1_3_5_88_1","unstructured":"Zymedyne Therapeutics Inc. Thiazolidine derivatives for inhibiting Cav3.2-USP5 interactions. US 2023\/0364061 A1. 2023."},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.18.1.37"},{"key":"e_1_3_5_90_1","unstructured":"Soochow University. Use of miloxacin in preparation of medicines for treating and\/or preventing diseases with T-type calcium channels as therapeutic target. US 2022\/0305002 A1. 2022."},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.073205"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800419w"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.07.090"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47199-1"},{"key":"e_1_3_5_95_1","unstructured":"Kinki University National University Corporation University of Toyama Fuso Pharmaceutical Industries Ltd. T-type calcium channel inhibitor. US 11673859 B2. 2023"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.06.020"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6099"},{"key":"e_1_3_5_98_1","unstructured":"Soochow University. Application of TNP-470 in preparation of medicine for treating and\/or preventing diseases with T-type calcium channel as target. CN 114617870 B 2023."},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(02)00514-8"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2008.10.039"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.03.021"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2023.12.015"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph3082362"},{"key":"e_1_3_5_104_1","unstructured":"Praxis Precision Medicines Inc. T-type calcium channel modulators and uses thereof. WO 2023\/150409 A2. 2023."},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01236"},{"key":"e_1_3_5_106_1","unstructured":"Idorsia Pharmaceuticals Ltd. Pharmaceutical combination comprising a T-type calcium channel blocker. US 2020\/0016139 A1. 2020."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2713553","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2026.2713553","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2713553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:26:01Z","timestamp":1788258361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2713553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":104,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/13543776.2026.2713553"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2713553","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}